Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Operating expenses:
Research and development expenses	$ 2,764,195	$ 1,414,225	$ 4,177,252	$ 3,385,904
General and administrative expenses	2,341,828	1,521,736	3,978,044	3,581,884
Total operating expenses	5,106,023	2,935,961	8,155,296	6,967,788
Loss from operations	(5,106,023)	(2,935,961)	(8,155,296)	(6,967,788)
Interest income	604	6,617	1,259	53,036
Loss before income taxes	(5,105,419)	(2,929,344)	(8,154,037)	(6,914,752)
Benefit for income taxes	4,516,488	0	4,516,488	0
Net loss	(588,931)	(2,929,344)	(3,637,549)	(6,914,752)
Comprehensive loss	$ (588,931)	$ (2,929,344)	$ (3,637,549)	$ (6,914,752)
Per share information:
Net loss per share, basic (in dollars per share)	$ (0.03)	$ (0.19)	$ (0.16)	$ (0.54)
Net loss per share, diluted (in dollars per share)	$ (0.03)	$ (0.19)	$ (0.16)	$ (0.54)
Weighted average common shares outstanding, basic (in shares)	23,160,371	15,357,199	22,714,581	12,835,980
Weighted average common shares outstanding, diluted (in shares)	23,160,371	15,357,199	22,714,581	12,835,980